• Financial Results

Eris Lifesciences Limited Q3FY22 Revenues at INR 3,322 mn, up 7.0% YoY

EBITDA at INR 1,217 mn, up 13.5% YoY PAT stood at INR 1,008 mn, up 11.8% YoY Mumbai, January 29,…